PREDICTING MEASURABLE RESIDUAL DISEASE FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS POSTTRANSPLANTATION

被引：0
作者：
Wang, Yue-Wen [1 ,2 ]
Fu, Guo-Mei [1 ,2 ]
Xu, Lan-Ping [1 ,2 ]
Wang, Yu [1 ,2 ]
Cheng, Yi-Fei [1 ,2 ]
Zhang, Yuan-Yuan [1 ,2 ]
Zhang, Xiao-Hui [1 ,2 ]
Liu, Yan-Rong [1 ,2 ]
Liu, Kai-Yan [1 ,2 ]
Huang, Xiao-Jun [1 ,2 ]
Chang, Ying-Jun [1 ,2 ]
机构：
[1] Peking Univ Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ Inst Hematol, Beijing, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P516
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [21] Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia
    Wong, Zoe C.
    Dillon, Laura W.
    Hourigan, Christopher S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (02)
  • [22] Comparison of Minimal/Measurable Residual Disease Assessment Techniques in patients with B-Lymphoblastic Leukemia
    El Karaaoui, Abdulkarim
    Ghannam, Samer Abi
    Khuja, Rayan
    Chakhachiro, Zaher
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1129 - S1129
  • [23] Minimal Residual Disease in Acute Lymphoblastic Leukemia
    Campana, Dario
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2010, : 7 - 12
  • [24] Minimal Residual Disease in Acute Lymphoblastic Leukemia
    Campana, Dario
    SEMINARS IN HEMATOLOGY, 2009, 46 (01) : 100 - 106
  • [25] Minimal Residual Disease in Acute Lymphoblastic Leukemia
    Patil, Pratik P.
    Jafa, Esha
    Aggarwal, Mayank
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 71 - 76
  • [26] Measurable Residual Disease Assessment and Allogeneic Transplantation as Consolidation Therapy in Adult Acute Lymphoblastic Leukemia in Colombia
    Felipe Combariza, Juan
    Arango, Marcos
    Diaz, Laura
    Agudelo, Claudia
    Hernandez, Sonia
    Maria Madera, Ana
    Leon, Guillermo
    Avila, Vladimir
    Bautista, Leonardo
    Valdes, Jaime
    Orduz, Rocio
    Mejia, Fabian
    Moreno, Liliana
    Ramirez, Carlos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04) : E365 - E372
  • [27] Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia
    Percival, Mary-Elizabeth M.
    Estey, Elihu H.
    CANCER, 2019, 125 (18) : 3121 - 3130
  • [28] Current assessment and management of measurable residual disease in patients with acute lymphoblastic leukemia in the setting of CAR-T-cell therapy
    Lin Minghao
    Zhao Xiaosu
    Chang Yingjun
    Zhao Xiangyu
    中华医学杂志英文版, 2024, 137 (02)
  • [29] Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
    Tecchio, Cristina
    Russignan, Anna
    Krampera, Mauro
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Achievement of Measurable Residual Disease (MRD) Negativity Supersedes Treatment Intensity in Predicting the Outcome of Patients with Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kadia, Tapan M.
    Short, Nicholas
    Borthakur, Gautam
    Wang, Sa A.
    Loghavi, Sanam
    Jorgensen, Jeffrey L.
    Patel, Keyur P.
    DiNardo, Courtney D.
    Daver, Naval
    Alvarado, Yesid
    Haddad, Fadi
    Pierce, Sherry A.
    Nogueras Gonzalez, Graciela M.
    Maiti, Abhishek
    Andreeff, Michael
    Jabbour, Elias
    Konopleva, Marina
    Huang, Xuelin
    Kantarjian, Hagop
    Ravandi, Farhad
    BLOOD, 2022, 140 : 2267 - 2269
12345